Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment
To investigate the natural history of renal cell carcinoma (RCC) with delayed treatment and to immunohistochemically analyze the correlation between some biomarkers and the growth rate of RCC. Methods: We reviewed our institutional databases to identify renal tumors which were confirmed to be RCC by...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-06-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664615001734 |
id |
doaj-9d77cce0b16f4662b6803744e9153f5a |
---|---|
record_format |
Article |
spelling |
doaj-9d77cce0b16f4662b6803744e9153f5a2020-11-24T22:28:10ZengElsevierJournal of the Formosan Medical Association0929-66462016-06-01115646346910.1016/j.jfma.2015.05.003Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatmentLei Zhang0Lin Yao1Xuesong Li2Michael A.S. Jewett3Zhisong He4Liqun Zhou5Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, ChinaDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, ChinaDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, ChinaDivision of Urology and Department of Surgical Oncology, Princess Margaret Hospital, University of Toronto, Toronto, CanadaDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, ChinaDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, ChinaTo investigate the natural history of renal cell carcinoma (RCC) with delayed treatment and to immunohistochemically analyze the correlation between some biomarkers and the growth rate of RCC. Methods: We reviewed our institutional databases to identify renal tumors which were confirmed to be RCC by delayed surgical treatment after at least 12 months of active surveillance (AS). Growth rate was defined as the average growth rate of the maximal diameter on computed tomography or magnetic resonance imaging. The clinicopathological characteristics and immunohistochemical biomarkers (Ki-67, p53, bcl-2, and vascular endothelial growth factor) were analyzed the correlation with the growth rate of RCC. Results: We identified 45 RCCs from 45 patients. The mean patient age was 54 years (range, 26–78 years). The mean tumor size increased from 2.39 cm (range, 0.10–6.70 cm) at presentation to 4.54 cm (range, 1.40–11.80 cm) after a mean time of 45.4 months (range, 12–155 months) of AS. The mean growth rate was 0.79 cm/y (range, 0.10–4.74 cm), and 36 (80.0%) tumors presented a growth rate ≤ 1.00 cm/y. Clear cell RCC had a trend of growing faster than other histological subtypes. Pathological grade was significantly correlated with the growth rate of RCC (p = 0.043). High positive ratio of Ki-67 (r = 0.351, p = 0.018) and being p53 positive (p = 0.019) were significantly correlated to the fast growth rate of RCC. Conclusion: In general, RCCs under AS are slow growing with a wide variation of growth rate, with a portion of RCCs presenting rapid growth kinetics. RCC with rapid growth during AS is characterized by a high histological grade, high positive ratio of Ki-67, and being p53 positive.http://www.sciencedirect.com/science/article/pii/S0929664615001734active surveillancedelayed interventiongrowth rateimmunohistochemical analysisrenal cell carcinoma |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lei Zhang Lin Yao Xuesong Li Michael A.S. Jewett Zhisong He Liqun Zhou |
spellingShingle |
Lei Zhang Lin Yao Xuesong Li Michael A.S. Jewett Zhisong He Liqun Zhou Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment Journal of the Formosan Medical Association active surveillance delayed intervention growth rate immunohistochemical analysis renal cell carcinoma |
author_facet |
Lei Zhang Lin Yao Xuesong Li Michael A.S. Jewett Zhisong He Liqun Zhou |
author_sort |
Lei Zhang |
title |
Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment |
title_short |
Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment |
title_full |
Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment |
title_fullStr |
Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment |
title_full_unstemmed |
Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment |
title_sort |
natural history of renal cell carcinoma: an immunohistochemical analysis of growth rate in patients with delayed treatment |
publisher |
Elsevier |
series |
Journal of the Formosan Medical Association |
issn |
0929-6646 |
publishDate |
2016-06-01 |
description |
To investigate the natural history of renal cell carcinoma (RCC) with delayed treatment and to immunohistochemically analyze the correlation between some biomarkers and the growth rate of RCC.
Methods: We reviewed our institutional databases to identify renal tumors which were confirmed to be RCC by delayed surgical treatment after at least 12 months of active surveillance (AS). Growth rate was defined as the average growth rate of the maximal diameter on computed tomography or magnetic resonance imaging. The clinicopathological characteristics and immunohistochemical biomarkers (Ki-67, p53, bcl-2, and vascular endothelial growth factor) were analyzed the correlation with the growth rate of RCC.
Results: We identified 45 RCCs from 45 patients. The mean patient age was 54 years (range, 26–78 years). The mean tumor size increased from 2.39 cm (range, 0.10–6.70 cm) at presentation to 4.54 cm (range, 1.40–11.80 cm) after a mean time of 45.4 months (range, 12–155 months) of AS. The mean growth rate was 0.79 cm/y (range, 0.10–4.74 cm), and 36 (80.0%) tumors presented a growth rate ≤ 1.00 cm/y. Clear cell RCC had a trend of growing faster than other histological subtypes. Pathological grade was significantly correlated with the growth rate of RCC (p = 0.043). High positive ratio of Ki-67 (r = 0.351, p = 0.018) and being p53 positive (p = 0.019) were significantly correlated to the fast growth rate of RCC.
Conclusion: In general, RCCs under AS are slow growing with a wide variation of growth rate, with a portion of RCCs presenting rapid growth kinetics. RCC with rapid growth during AS is characterized by a high histological grade, high positive ratio of Ki-67, and being p53 positive. |
topic |
active surveillance delayed intervention growth rate immunohistochemical analysis renal cell carcinoma |
url |
http://www.sciencedirect.com/science/article/pii/S0929664615001734 |
work_keys_str_mv |
AT leizhang naturalhistoryofrenalcellcarcinomaanimmunohistochemicalanalysisofgrowthrateinpatientswithdelayedtreatment AT linyao naturalhistoryofrenalcellcarcinomaanimmunohistochemicalanalysisofgrowthrateinpatientswithdelayedtreatment AT xuesongli naturalhistoryofrenalcellcarcinomaanimmunohistochemicalanalysisofgrowthrateinpatientswithdelayedtreatment AT michaelasjewett naturalhistoryofrenalcellcarcinomaanimmunohistochemicalanalysisofgrowthrateinpatientswithdelayedtreatment AT zhisonghe naturalhistoryofrenalcellcarcinomaanimmunohistochemicalanalysisofgrowthrateinpatientswithdelayedtreatment AT liqunzhou naturalhistoryofrenalcellcarcinomaanimmunohistochemicalanalysisofgrowthrateinpatientswithdelayedtreatment |
_version_ |
1725747565626916864 |